Literature DB >> 29174778

Association of Donor Tricuspid Valve Repair With Outcomes After Cardiac Transplantation.

Joshua Greenberg1, Nicholas R Teman2, Jonathan W Haft3, Matthew A Romano3, Francis D Pagani3, Keith D Aaronson1, Audrey H Wu4.   

Abstract

BACKGROUND: Tricuspid regurgitation after cardiac transplantation is associated with worse clinical outcomes. This study sought to determine the association of donor tricuspid valve repair (dTVR) with outcomes after cardiac transplantation.
METHODS: Patients who underwent cardiac transplantation between January 20, 2002, and December 31, 2016, were included. Multivariable Cox regression modeling was performed to determine the association between dTVR and the composite outcome of death, posttransplant TVR, kidney transplant after cardiac transplant, or chronic dialysis, and included propensity scoring to control for baseline differences in likelihood of undergoing dTVR.
RESULTS: The analysis included 330 patients, with 173 (52.4%) undergoing dTVR. dTVR performance varied by surgeon and also increased over time, with 71 (83.5%) performed during January 1, 2011, to November 30, 2013. Transplant year and surgeon were significantly associated with the baseline likelihood of undergoing dTVR. Although fewer composite outcomes occurred in the dTVR vs no dTVR group (39 [22.5%] vs 56 [36.4%], p = 0.006), dTVR was not significantly associated with the composite outcome in multivariable modeling. Lower risk for the composite outcome was associated with greater number of biopsies during the first posttransplant year, whereas higher risk was associated with more high-grade biopsy specimens and higher creatinine.
CONCLUSIONS: There was no significant benefit or harm with regards to the composite of death, posttransplant TVR, or dialysis associated with dTVR.
Copyright © 2018 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29174778     DOI: 10.1016/j.athoracsur.2017.08.024

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Tricuspid Valve Regurgitation Immediately After Heart Transplant and Long-Term Outcomes.

Authors:  Muath Bishawi; Giorgio Zanotti; Linda Shaw; Michael MacKenzie; Anthony Castleberry; Karsten Bartels; Jacob Schroder; Eric Velazquez; Madhav Swaminathan; Joseph Rogers; Carmelo Milano
Journal:  Ann Thorac Surg       Date:  2018-12-05       Impact factor: 4.330

2.  Tricuspid Valve Regurgitation After Heart Transplantation: A Single-Center 10-year Experience.

Authors:  Khaled D Algarni; Amr A Arafat; Claudio Pragliola; Yahya S Alhebaishi; Latifa A AlFayez; Khaled AlOtaibi; Abeer M Bakhsh; Ahmed A Amro; Adam I Adam
Journal:  J Saudi Heart Assoc       Date:  2020-05-20

Review 3.  A Meta-Analysis on Prophylactic Donor Heart Tricuspid Annuloplasty in Orthotopic Heart Transplantation: High Hopes from a Small Intervention.

Authors:  Alberto Emanuel Bacusca; Andrei Tarus; Alexandru Burlacu; Mihail Enache; Grigore Tinica
Journal:  Healthcare (Basel)       Date:  2021-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.